{"transactions":[{"id":680003,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":27052,"price":1.4199,"value":38411.1348,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.47, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":680002,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":222948,"price":1.4199,"value":316563.8652,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.47, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":680001,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":27051,"price":1.4407,"value":38972.3757,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.50, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":27052,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":680000,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":222949,"price":1.4407,"value":321202.6243,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.50, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":222948,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":679999,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":27826,"price":1.3712,"value":38155.0112,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.345 to $1.40, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54103,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":679998,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-20T21:00:50.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":229338,"price":1.3712,"value":314468.2656,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.345 to $1.40, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":445897,"source":{"system":"sec-edgar","filing":"0001193125-26-359349","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526359349/ownership.xml","form_type":"4"}},{"id":694273,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney Holdings, LLC","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":false,"shares":675235,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":675235},"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694272,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":false,"shares":675235,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Class B Common Stock and the Common Units in ProKidney Holdings LLC (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Amended and Restated Exchange Agreement, dated as of July 1, 2025, and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, LLC, each share of Class B Common Stock, together with a paired Common Unit, may be exchanged for a share of Class A Common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The shares of Class B Common Stock do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The shares of Class B Common Stock do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":675235},"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694271,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney Holdings, LLC","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":false,"shares":81929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":81929},"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694270,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":false,"shares":81929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Class B Common Stock and the Common Units in ProKidney Holdings LLC (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Amended and Restated Exchange Agreement, dated as of July 1, 2025, and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, LLC, each share of Class B Common Stock, together with a paired Common Unit, may be exchanged for a share of Class A Common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The shares of Class B Common Stock do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The shares of Class B Common Stock do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":81929},"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694269,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":true,"shares":675235,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"balance_after":675235,"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":694268,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-06T12:09:30.000Z","date":"2026-08-04","kind":"exercise","planned":false,"acquired":true,"shares":81929,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81929,"source":{"system":"sec-edgar","filing":"0001193125-26-336856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526336856/ownership.xml","form_type":"4"}},{"id":715441,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":32168,"kind":"person","name":"Locke Kenneth Thomas","position":1,"cik":"0002139380","reported_name":"Locke Kenneth Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-07-06T20:02:26.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on 1st anniversary of July 1, 2026 and the remaining 75% vests in substantially equal monthly installments for 36 months thereafter, subject to continued employment."}],"balance_after":750000,"derivative":{"exercise_price":1.89,"expiration_date":"2036-07-01","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001193125-26-296160","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526296160/ownership.xml","form_type":"4"}},{"id":737930,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Units in ProKidney Holdings, LLC","published_at":"2026-06-15T21:32:30.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":false,"shares":163857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":163857},"source":{"system":"sec-edgar","filing":"0001193125-26-271337","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526271337/ownership.xml","form_type":"4"}},{"id":737929,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class B Common Stock","published_at":"2026-06-15T21:32:30.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":false,"shares":163857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Common Stock and the Common Units in ProKidney Holdings LLC (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Amended and Restated Exchange Agreement, dated as of July 1, 2025, and and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, LLC, each Class B Common Stock, together with a paired Common Unit, may be exchanged for Class A Common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Stock do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Common Stock were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Stock do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":163857},"source":{"system":"sec-edgar","filing":"0001193125-26-271337","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526271337/ownership.xml","form_type":"4"}},{"id":737928,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-15T21:32:30.000Z","date":"2026-06-12","kind":"exercise","planned":false,"acquired":true,"shares":163857,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":327713,"source":{"system":"sec-edgar","filing":"0001193125-26-271337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526271337/ownership.xml","form_type":"4"}},{"id":758845,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:07:30.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248262/ownership.xml","form_type":"4"}},{"id":758843,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43194,"kind":"person","name":"Jimenez Santos Jose Ignacio","position":1,"cik":"0001937007","reported_name":"Jimenez Santos Jose Ignacio","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:06:51.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248259","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248259/ownership.xml","form_type":"4"}},{"id":758844,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":1945,"kind":"person","name":"Fox Jennifer A.","position":1,"cik":"0001841557","reported_name":"Fox Jennifer A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:06:13.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248256/ownership.xml","form_type":"4"}},{"id":758842,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:05:36.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248249/ownership.xml","form_type":"4"}},{"id":758841,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43192,"kind":"person","name":"Sinha Uma","position":1,"cik":"0001742587","reported_name":"Sinha Uma","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:04:56.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248226/ownership.xml","form_type":"4"}},{"id":758840,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:04:17.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248221","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248221/ownership.xml","form_type":"4"}},{"id":758839,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:03:34.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248215/ownership.xml","form_type":"4"}},{"id":796979,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Common Units in ProKidney LLC","published_at":"2026-04-30T20:12:46.000Z","date":"2026-04-28","kind":"exercise","planned":false,"acquired":false,"shares":63118645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement, each Class B Common Share, together with a paired Common Unit, may be exchanged for a Class A Common Share on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Prior to April 28, 2026 (the \"Transaction Date\"), the reporting persons beneficially owned 63,118,645 Class B Common Shares, $0.0001 par value per share (the \"Class B Common Shares\") of ProKidney Corp. (the \"Issuer\"), each of which may, subject to the limitations set forth in the Amended and Restated Exchange Agreement (the \"Exchange Agreement\") and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, be exchanged, together with the paired common unit (a \"Common Unit,\" and together with the Class B Common Shares, the \"Paired Interests\") in  ProKidney Holdings, LLC ( \"ProKidney LLC\"), for a Class A Common Share on a one-for-one basis. Prior to the Transaction Date, the reporting person owned 63,118,645 Paired Interests. On the Transaction Date, the reporting person exchanged 63,118,645 Paired Interests for 63,118,645 Class A Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":63118645},"source":{"system":"sec-edgar","filing":"0001140361-26-018234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036126018234/form4.xml","form_type":"4"}},{"id":796978,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class B Common Shares","published_at":"2026-04-30T20:12:46.000Z","date":"2026-04-28","kind":"exercise","planned":false,"acquired":false,"shares":63118645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement, each Class B Common Share, together with a paired Common Unit, may be exchanged for a Class A Common Share on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Prior to April 28, 2026 (the \"Transaction Date\"), the reporting persons beneficially owned 63,118,645 Class B Common Shares, $0.0001 par value per share (the \"Class B Common Shares\") of ProKidney Corp. (the \"Issuer\"), each of which may, subject to the limitations set forth in the Amended and Restated Exchange Agreement (the \"Exchange Agreement\") and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, be exchanged, together with the paired common unit (a \"Common Unit,\" and together with the Class B Common Shares, the \"Paired Interests\") in  ProKidney Holdings, LLC ( \"ProKidney LLC\"), for a Class A Common Share on a one-for-one basis. Prior to the Transaction Date, the reporting person owned 63,118,645 Paired Interests. On the Transaction Date, the reporting person exchanged 63,118,645 Paired Interests for 63,118,645 Class A Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class B Common Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Class B Common Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Common Shares do not expire."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":63118645},"source":{"system":"sec-edgar","filing":"0001140361-26-018234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036126018234/form4.xml","form_type":"4"}},{"id":796977,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Common Shares (as defined in Exhibit 99.1 hereto)","published_at":"2026-04-30T20:12:46.000Z","date":"2026-04-28","kind":"exercise","planned":false,"acquired":true,"shares":63118645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Prior to April 28, 2026 (the \"Transaction Date\"), the reporting persons beneficially owned 63,118,645 Class B Common Shares, $0.0001 par value per share (the \"Class B Common Shares\") of ProKidney Corp. (the \"Issuer\"), each of which may, subject to the limitations set forth in the Amended and Restated Exchange Agreement (the \"Exchange Agreement\") and the Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings, be exchanged, together with the paired common unit (a \"Common Unit,\" and together with the Class B Common Shares, the \"Paired Interests\") in  ProKidney Holdings, LLC ( \"ProKidney LLC\"), for a Class A Common Share on a one-for-one basis. Prior to the Transaction Date, the reporting person owned 63,118,645 Paired Interests. On the Transaction Date, the reporting person exchanged 63,118,645 Paired Interests for 63,118,645 Class A Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Form 4 filed by the reporting person on March 16, 2024 and prior to the date hereof inadvertently aggregated 63,118,645 Paired Interests in Table I."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":73842723,"source":{"system":"sec-edgar","filing":"0001140361-26-018234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036126018234/form4.xml","form_type":"4"}},{"id":868045,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63362,"kind":"person","name":"Coulston James","position":1,"cik":"0001936203","reported_name":"Coulston James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-03-03T12:59:02.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2026."}],"balance_after":600000,"derivative":{"exercise_price":2.24,"expiration_date":"2036-03-01","underlying":"Class A Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001193125-26-086730","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526086730/ownership.xml","form_type":"4"}},{"id":868044,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-03-03T12:58:18.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2026."}],"balance_after":600000,"derivative":{"exercise_price":2.24,"expiration_date":"2036-03-01","underlying":"Class A Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001193125-26-086725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526086725/ownership.xml","form_type":"4"}},{"id":868043,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63361,"kind":"person","name":"Culleton Bruce","position":1,"cik":"0001983742","reported_name":"Culleton Bruce","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-03-03T12:57:59.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2026."}],"balance_after":3000000,"derivative":{"exercise_price":2.24,"expiration_date":"2036-03-01","underlying":"Class A Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001193125-26-086724","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526086724/ownership.xml","form_type":"4"}},{"id":868352,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-03-03T07:58:38.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2026."}],"balance_after":400000,"derivative":{"exercise_price":2.24,"expiration_date":"2036-03-01","underlying":"Class A Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001193125-26-086728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000119312526086728/ownership.xml","form_type":"4"}},{"id":998961,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-14T21:07:02.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":54333,"price":2.37,"value":128769.21,"ownership":{"direct":false,"nature":"Brian J. G. Pereira 2004 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-282922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312525282922/ownership.xml","form_type":"4"}},{"id":998960,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-14T21:07:02.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":447803,"price":2.37,"value":1061293.11,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-282922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312525282922/ownership.xml","form_type":"4"}},{"id":998959,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-14T21:07:02.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":27595,"price":2.7234,"value":75152.223,"ownership":{"direct":false,"nature":"Brian J. G. Pereira 2004 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54333,"source":{"system":"sec-edgar","filing":"0001193125-25-282922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312525282922/ownership.xml","form_type":"4"}},{"id":998958,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-11-14T21:07:02.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":227431,"price":2.7233,"value":619362.8423,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":447803,"source":{"system":"sec-edgar","filing":"0001193125-25-282922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312525282922/ownership.xml","form_type":"4"}},{"id":1090079,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-09T16:28:11.000Z","date":"2025-07-08","kind":"sale","planned":true,"acquired":false,"shares":103480,"price":3.02,"value":312509.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of stock occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 15, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-094797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017025094797/ownership.xml","form_type":"4"}},{"id":1121607,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2025-06-05T16:15:27.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":false,"shares":3823996,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (the \"Common Units\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by Tolerantia, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the equity interests held by Tolerantia except to the extent of his indirect pecuniary interest therein."}],"balance_after":84283430,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":3823996},"source":{"system":"sec-edgar","filing":"0000950170-25-082342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017025082342/ownership.xml","form_type":"4"}},{"id":1121606,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2025-06-05T16:15:27.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":false,"shares":3823996,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (the \"Common Units\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by Tolerantia, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the equity interests held by Tolerantia except to the extent of his indirect pecuniary interest therein."}],"balance_after":84283430,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":3823996},"source":{"system":"sec-edgar","filing":"0000950170-25-082342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017025082342/ownership.xml","form_type":"4"}},{"id":1121605,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-06-05T16:15:27.000Z","date":"2025-06-03","kind":"other","planned":false,"acquired":false,"shares":3823996,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Prior to June 3, 2025 (the \"Transaction Date\"), Tolerantia held 88,107,426 Common Units in ProKidney and an equal number of Class B Ordinary Shares (the \"Paired Interests\"), 84,160,537 of which were held by Nefro Health, an Irish partnership that is an affiliate controlled and majority-owned by Mr. Pablo Legorreta, and 3,946,889 of which were held by other investors which are unaffiliated with Mr. Legorreta (the \"Unaffiliated Investors\"). On the Transaction Date, Tolerantia exchanged 3,823,996 of the 3,946,889 Paired Interests attributable to the interests of the Unaffiliated Investors in Tolerantia for 3,823,996 Class A Ordinary Shares, which it subsequently distributed in-kind pro rata for no consideration to the Unaffiliated Investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by Tolerantia, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the equity interests held by Tolerantia except to the extent of his indirect pecuniary interest therein."}],"balance_after":22617909,"source":{"system":"sec-edgar","filing":"0000950170-25-082342","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017025082342/ownership.xml","form_type":"4"}},{"id":1121604,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-06-05T16:15:27.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":3823996,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by Tolerantia, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the equity interests held by Tolerantia except to the extent of his indirect pecuniary interest therein."}],"balance_after":26441905,"source":{"system":"sec-edgar","filing":"0000950170-25-082342","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017025082342/ownership.xml","form_type":"4"}},{"id":1127797,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:15:29.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080277/ownership.xml","form_type":"4"}},{"id":1127796,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43192,"kind":"person","name":"Sinha Uma","position":1,"cik":"0001742587","reported_name":"Sinha Uma","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:14:48.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080272/ownership.xml","form_type":"4"}},{"id":1127795,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:14:20.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080269/ownership.xml","form_type":"4"}},{"id":1127794,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43194,"kind":"person","name":"Jimenez Santos Jose Ignacio","position":1,"cik":"0001937007","reported_name":"Jimenez Santos Jose Ignacio","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:13:49.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080267/ownership.xml","form_type":"4"}},{"id":1127793,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":1945,"kind":"person","name":"Fox Jennifer A.","position":1,"cik":"0001841557","reported_name":"Fox Jennifer A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:13:12.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080265","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080265/ownership.xml","form_type":"4"}},{"id":1127792,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:12:53.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080261/ownership.xml","form_type":"4"}},{"id":1127791,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:12:15.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080260","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080260/ownership.xml","form_type":"4"}},{"id":1166432,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2025-04-24T20:15:43.000Z","date":"2025-04-22","kind":"purchase","planned":false,"acquired":true,"shares":387393,"price":0.7134,"value":276366.1662,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6832 to $0.73 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":73842723,"source":{"system":"sec-edgar","filing":"0001140361-25-015444","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125015444/form4.xml","form_type":"4"}},{"id":1168447,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2025-04-21T20:37:34.000Z","date":"2025-04-17","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.7476,"value":18690.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7452 to $0.7479 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":73455330,"source":{"system":"sec-edgar","filing":"0001140361-25-014756","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125014756/form4.xml","form_type":"4"}},{"id":1169125,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2025-04-18T20:15:51.000Z","date":"2025-04-16","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.7482,"value":74820.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7472 to $0.75 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":73430330,"source":{"system":"sec-edgar","filing":"0001140361-25-014571","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125014571/form4.xml","form_type":"4"}},{"id":1171053,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2025-04-16T21:04:38.000Z","date":"2025-04-15","kind":"purchase","planned":false,"acquired":true,"shares":468000,"price":0.6966,"value":326008.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6702 to $0.70 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":73330330,"source":{"system":"sec-edgar","filing":"0001140361-25-014211","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125014211/form4.xml","form_type":"4"}},{"id":1171052,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2025-04-16T21:04:38.000Z","date":"2025-04-14","kind":"purchase","planned":false,"acquired":true,"shares":268105,"price":0.7258,"value":194590.609,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.71 to $0.74 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":72862330,"source":{"system":"sec-edgar","filing":"0001140361-25-014211","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125014211/form4.xml","form_type":"4"}},{"id":1172639,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2025-04-14T20:30:14.000Z","date":"2025-04-11","kind":"purchase","planned":false,"acquired":true,"shares":1900,"price":0.6081,"value":1155.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6057 to $0.61 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":72594225,"source":{"system":"sec-edgar","filing":"0001140361-25-013770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125013770/form4.xml","form_type":"4"}},{"id":1172638,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2025-04-14T20:30:14.000Z","date":"2025-04-10","kind":"purchase","planned":false,"acquired":true,"shares":1032218,"price":0.6081,"value":627691.7658,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.575 to $0.61 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":72592325,"source":{"system":"sec-edgar","filing":"0001140361-25-013770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036125013770/form4.xml","form_type":"4"}},{"id":1229312,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63361,"kind":"person","name":"Culleton Bruce","position":1,"cik":"0001983742","reported_name":"Culleton Bruce","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-03-04T21:42:14.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":1796000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2025."}],"balance_after":1796000,"derivative":{"exercise_price":1.23,"expiration_date":"2035-03-01","underlying":"Class A Ordinary Shares","underlying_shares":1796000},"source":{"system":"sec-edgar","filing":"0000950170-25-032255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025032255/ownership.xml","form_type":"4"}},{"id":1229311,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-03-04T21:41:36.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2025."}],"balance_after":650000,"derivative":{"exercise_price":1.23,"expiration_date":"2035-03-01","underlying":"Class A Ordinary Shares","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0000950170-25-032249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025032249/ownership.xml","form_type":"4"}},{"id":1229310,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63362,"kind":"person","name":"Coulston James","position":1,"cik":"0001936203","reported_name":"Coulston James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-03-04T21:41:06.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2025."}],"balance_after":650000,"derivative":{"exercise_price":1.23,"expiration_date":"2035-03-01","underlying":"Class A Ordinary Shares","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0000950170-25-032247","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025032247/ownership.xml","form_type":"4"}},{"id":1229664,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-03-04T16:41:51.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2025."}],"balance_after":450000,"derivative":{"exercise_price":1.23,"expiration_date":"2035-03-01","underlying":"Class A Ordinary Shares","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0000950170-25-032251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017025032251/ownership.xml","form_type":"4"}},{"id":1280385,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":675234,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":675235,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":675234},"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280384,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":675234,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each filed as an Issuer's Annual Report on Form 10-K filed on March 22, 2024), each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."}],"balance_after":675235,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":675234},"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280383,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":81929,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280382,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each filed as an Issuer's Annual Report on Form 10-K filed on March 22, 2024), each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."}],"balance_after":81929,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280381,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":true,"shares":675234,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Brian J. G. Pereira 2012 Irrevocable Trust"},"balance_after":675234,"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280380,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-06T21:05:03.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":true,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81928,"source":{"system":"sec-edgar","filing":"0000950170-25-015369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025015369/ownership.xml","form_type":"4"}},{"id":1280457,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2025-02-06T17:02:57.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":532535,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (the \"Common Units\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by Tolerantia, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the equity interests held by Tolerantia except to the extent of his indirect pecuniary interest therein."}],"balance_after":88107426,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":532535},"source":{"system":"sec-edgar","filing":"0000950170-25-015495","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017025015495/ownership.xml","form_type":"4"}},{"id":1280456,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2025-02-06T17:02:57.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":false,"shares":532535,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (the \"Common Units\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by Tolerantia, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the equity interests held by Tolerantia except to the extent of his indirect pecuniary interest therein."}],"balance_after":88107426,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":532535},"source":{"system":"sec-edgar","filing":"0000950170-25-015495","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017025015495/ownership.xml","form_type":"4"}},{"id":1280455,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-06T17:02:57.000Z","date":"2025-02-04","kind":"other","planned":false,"acquired":false,"shares":532535,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Prior to February 4, 2025 (the \"Transaction Date\"), Tolerantia held 88,639,961 Common Units in ProKidney and an equal number of Class B Ordinary Shares (the \"Paired Interests\"), 84,160,537 of which were held by Nefro Health, an Irish partnership that is an affiliate controlled and majority-owned by Mr. Pablo Legorreta, and 4,479,424 of which were held by other investors which are unaffiliated with Mr. Legorreta (the \"Unaffiliated Investors\"). On the Transaction Date, Tolerantia exchanged 532,535 of the 4,479,424 Paired Interests attributable to the interests of the Unaffiliated Investors in Tolerantia for 532,535 Class A Ordinary Shares, which it subsequently distributed in-kind pro rata for no consideration to the Unaffiliated Investors."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by Tolerantia, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the equity interests held by Tolerantia except to the extent of his indirect pecuniary interest therein."}],"balance_after":22617909,"source":{"system":"sec-edgar","filing":"0000950170-25-015495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017025015495/ownership.xml","form_type":"4"}},{"id":1280454,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-02-06T17:02:57.000Z","date":"2025-02-04","kind":"exercise","planned":false,"acquired":true,"shares":532535,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by Tolerantia, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia. Mr. Legorreta disclaims beneficial ownership of the equity interests held by Tolerantia except to the extent of his indirect pecuniary interest therein."}],"balance_after":23150444,"source":{"system":"sec-edgar","filing":"0000950170-25-015495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017025015495/ownership.xml","form_type":"4"}},{"id":1401729,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-09-20T16:44:11.000Z","date":"2024-09-19","kind":"sale","planned":true,"acquired":false,"shares":16412,"price":2.5,"value":41030.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."}],"balance_after":103480,"source":{"system":"sec-edgar","filing":"0000950170-24-108438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024108438/ownership.xml","form_type":"4"}},{"id":1406723,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63361,"kind":"person","name":"Culleton Bruce","position":1,"cik":"0001983742","reported_name":"Culleton Bruce","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2024-09-16T21:31:15.000Z","date":"2024-09-13","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This performance-based stock option was granted on December 3, 2023. On September 13, 2024, the Company's board of directors certified achievement of the performance goal at 100%.  In addition to the achievement of the performance goal, the options are subject to time vesting requirements under which 25% vested on September 13, 2024 and the remaining 75% vests in equal installments of 125,000 shares on each of November 15, 2024, February 15, 2025 and May 15, 2025."}],"balance_after":500000,"derivative":{"exercise_price":1.69,"expiration_date":"2033-12-03","underlying":"Class A Ordinary Shares","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950170-24-106912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024106912/ownership.xml","form_type":"4"}},{"id":1415942,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":1945,"kind":"person","name":"Fox Jennifer A.","position":1,"cik":"0001841557","reported_name":"Fox Jennifer A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-09-05T00:03:01.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":9535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on July 11, 2025 subject to Ms. Fox's continued service with the Company through the applicable vesting date."}],"balance_after":9535,"derivative":{"exercise_price":2.4,"expiration_date":"2034-09-03","underlying":"Class A Ordinary Shares","underlying_shares":9535},"source":{"system":"sec-edgar","filing":"0000950170-24-103630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024103630/ownership.xml","form_type":"4"}},{"id":1443015,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Units in ProKidney LP","published_at":"2024-08-02T20:03:07.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire."}],"balance_after":163857,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-24-089935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024089935/ownership.xml","form_type":"4"}},{"id":1443014,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class B Ordinary Shares","published_at":"2024-08-02T20:03:07.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Class B Ordinary Shares and the Common Units in ProKidney LP (a \"Common Unit\") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire."}],"balance_after":163857,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":81928},"source":{"system":"sec-edgar","filing":"0000950170-24-089935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024089935/ownership.xml","form_type":"4"}},{"id":1443013,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-08-02T20:03:07.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":true,"shares":81928,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":163856,"source":{"system":"sec-edgar","filing":"0000950170-24-089935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024089935/ownership.xml","form_type":"4"}},{"id":1447249,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-07-29T16:02:53.000Z","date":"2024-07-26","kind":"sale","planned":true,"acquired":false,"shares":826,"price":2.5,"value":2065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.51, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":119892,"source":{"system":"sec-edgar","filing":"0000950170-24-087273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024087273/ownership.xml","form_type":"4"}},{"id":1469610,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2024-06-25T20:06:47.000Z","date":"2024-06-11","kind":"purchase","planned":false,"acquired":true,"shares":8264462,"price":2.42,"value":19999998.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":71560107,"source":{"system":"sec-edgar","filing":"0001140361-24-031298","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036124031298/form4.xml","form_type":"4"}},{"id":1473476,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-06-20T16:03:26.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":17238,"price":2.8203,"value":48616.3314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.99, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120718,"source":{"system":"sec-edgar","filing":"0000950170-24-075563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024075563/ownership.xml","form_type":"4"}},{"id":1479407,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78846,"kind":"organization","name":"Tolerantia, LLC","position":2,"cik":"0001937011","reported_name":"Tolerantia, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2024-06-14T16:05:17.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":22617909,"price":2.42,"value":54735339.78,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents equity interests held by or for the benefit of Tolerantia, LLC, which is an affiliate controlled and majority owned by Pablo Legorreta. Mr. Legorreta controls the voting and disposition of the equity interests held by Tolerantia, LLC. Mr. Legorreta disclaims beneficial ownership of the equity interests held by or for the benefit of Tolerantia, LLC except to the extent of his indirect pecuniary interest therein."}],"balance_after":22617909,"source":{"system":"sec-edgar","filing":"0000950170-24-073633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937011/000095017024073633/ownership.xml","form_type":"4"}},{"id":1495284,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":1945,"kind":"person","name":"Fox Jennifer A.","position":1,"cik":"0001841557","reported_name":"Fox Jennifer A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:58:47.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068072/ownership.xml","form_type":"4"}},{"id":1495283,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43192,"kind":"person","name":"Sinha Uma","position":1,"cik":"0001742587","reported_name":"Sinha Uma","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:34:09.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068047/ownership.xml","form_type":"4"}},{"id":1495285,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":25466,"kind":"person","name":"Legorreta Pablo G.","position":1,"cik":"0001507678","reported_name":"Legorreta Pablo G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:33:37.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068045/ownership.xml","form_type":"4"}},{"id":1495282,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":21262,"kind":"person","name":"Pereira Brian JG","position":1,"cik":"0001298146","reported_name":"Pereira Brian JG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:32:59.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068043","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068043/ownership.xml","form_type":"4"}},{"id":1495281,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43194,"kind":"person","name":"Jimenez Santos Jose Ignacio","position":1,"cik":"0001937007","reported_name":"Jimenez Santos Jose Ignacio","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:32:34.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068040/ownership.xml","form_type":"4"}},{"id":1495280,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":43193,"kind":"person","name":"DOYLE WILLIAM F","position":1,"cik":"0001194459","reported_name":"DOYLE WILLIAM F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:31:39.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068038/ownership.xml","form_type":"4"}},{"id":1495279,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:31:06.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068034/ownership.xml","form_type":"4"}},{"id":1505764,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Regulatory Officer"}}],"security":"Class A Ordinary Shares","published_at":"2024-05-22T07:22:10.000Z","date":"2024-05-20","kind":"sale","planned":true,"acquired":false,"shares":17238,"price":4.0832,"value":70386.2016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.74 to $4.44, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":137956,"source":{"system":"sec-edgar","filing":"0000950170-24-063281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024063281/ownership.xml","form_type":"4"}},{"id":1514444,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2024-05-17T00:22:03.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":1.4318,"value":42954.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.4300 to $1.4399 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (5) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":63295645,"source":{"system":"sec-edgar","filing":"0001140361-24-026549","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036124026549/form4.xml","form_type":"4"}},{"id":1514443,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2024-05-17T00:22:03.000Z","date":"2024-03-22","kind":"purchase","planned":false,"acquired":true,"shares":14000,"price":1.399,"value":19586.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.3800 to $1.4000 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":63265645,"source":{"system":"sec-edgar","filing":"0001140361-24-026549","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036124026549/form4.xml","form_type":"4"}},{"id":1514442,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2024-05-17T00:22:03.000Z","date":"2024-03-20","kind":"purchase","planned":false,"acquired":true,"shares":33000,"price":1.3973,"value":46110.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.3890 to $1.4000 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":63251645,"source":{"system":"sec-edgar","filing":"0001140361-24-026549","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036124026549/form4.xml","form_type":"4"}},{"id":1514441,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2024-05-17T00:22:03.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.3585,"value":67925.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.3550 to $1.3600 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":63218645,"source":{"system":"sec-edgar","filing":"0001140361-24-026549","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036124026549/form4.xml","form_type":"4"}},{"id":1514440,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":10032,"kind":"organization","name":"Control Empresarial de Capitales S.A. de C.V.","position":1,"cik":"0001273693","reported_name":"Control Empresarial de Capitales S.A. de C.V.","relationship":{"ten_percent_owner":true,"other":true,"other_text":"Add'l Rep. Persons-see Ex.99-1"}}],"security":"Class A Ordinary Shares (as defined in Exhibit 99.1 hereto)","published_at":"2024-05-17T00:22:03.000Z","date":"2024-03-13","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.5018,"value":75090.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.4900 to $1.5018 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 63,118,645 Class B Ordinary Shares, $0.0001 par value per share (the \"Class B Ordinary Shares\"), each of which has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the SEC on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis. The reporting person beneficially owns 63,118,645 Common Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Excludes 6,999,999 Earnout Rights received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney LP, dated as of January 18, 2022 (the \"Business Combination Agreement\"). Pursuant to the earnout provisions of the Business Combination Agreement, the reporting person is entitled to receive earnout restricted Common Units (\"Earnout RCUs\") and earnout restricted Class B Ordinary Shares (\"Earnout RSRs\" and together with the Earnout RCS, the \"Earnout Rights\") that vest in three equal tranches based on the achievement of share price milestones set forth in footnote (8) below. Once vested, the Earnout RCUs will automatically convert into Common Units and the Earnout RSRs will automatically convert into Class B Ordinary Shares, which, as noted in footnote (6) above, may be exchanged for Class A Ordinary Shares at the election of the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"One-third of the Earnout Rights will vest upon the volume weighted average price (\"VWAP\") of a Class A Ordinary Share reaching $15.00 per share for any 20 trading days over any consecutive 30 day trading period, an additional one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $20.00 per share for any 20 trading days over any consecutive 30 day trading period and the final one-third of the Earnout Rights will vest upon the VWAP of a Class A Ordinary Share reaching $25.00 per share for any 20 trading days over any consecutive 30 day trading period, in each case, such share price milestone must be achieved by the fifth anniversary of the closing of the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F9","text":"See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference."}],"balance_after":63168645,"source":{"system":"sec-edgar","filing":"0001140361-24-026549","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000114036124026549/form4.xml","form_type":"4"}},{"id":1536968,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Development"}}],"security":"Class A Ordinary Shares","published_at":"2024-04-23T16:05:49.000Z","date":"2024-04-22","kind":"sale","planned":true,"acquired":false,"shares":16438,"price":2.5134,"value":41315.2692,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.53, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."}],"balance_after":155194,"source":{"system":"sec-edgar","filing":"0000950170-24-046887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024046887/ownership.xml","form_type":"4"}},{"id":1536967,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Development"}}],"security":"Class A Ordinary Shares","published_at":"2024-04-23T16:05:49.000Z","date":"2024-04-18","kind":"sale","planned":true,"acquired":false,"shares":800,"price":2.535,"value":2028.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.55, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."}],"balance_after":171632,"source":{"system":"sec-edgar","filing":"0000950170-24-046887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024046887/ownership.xml","form_type":"4"}},{"id":1540189,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Development"}}],"security":"Class A Ordinary Shares","published_at":"2024-04-17T18:57:28.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":17238,"price":2.5,"value":43095.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."}],"balance_after":172432,"source":{"system":"sec-edgar","filing":"0000950170-24-045248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024045248/ownership.xml","form_type":"4"}},{"id":1541358,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Development"}}],"security":"Class A Ordinary Shares","published_at":"2024-04-16T16:54:12.000Z","date":"2024-04-12","kind":"sale","planned":true,"acquired":false,"shares":84103,"price":1.73,"value":145498.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.77, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."}],"balance_after":189670,"source":{"system":"sec-edgar","filing":"0000950170-24-044836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024044836/ownership.xml","form_type":"4"}},{"id":1541357,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Development"}}],"security":"Class A Ordinary Shares","published_at":"2024-04-16T16:54:12.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":300,"price":1.69,"value":507.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023."}],"balance_after":273773,"source":{"system":"sec-edgar","filing":"0000950170-24-044836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024044836/ownership.xml","form_type":"4"}},{"id":1554097,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":92367,"kind":"person","name":"Ernst Ulrich Peter Alfred","position":1,"cik":"0002016924","reported_name":"Ernst Ulrich Peter Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Technical Operations"}}],"security":"Employee stock option (right to buy)","published_at":"2024-04-02T16:05:53.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":335000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on 1st anniversary of April 1, 2024 and the remaining 75% vests in substantially equal monthly installments for 36 months thereafter."}],"balance_after":335000,"derivative":{"exercise_price":1.6,"expiration_date":"2034-04-01","underlying":"Class A Ordinary Shares","underlying_shares":335000},"source":{"system":"sec-edgar","filing":"0000950170-24-040140","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2016924/000095017024040140/ownership.xml","form_type":"4"}},{"id":1597208,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63362,"kind":"person","name":"Coulston James","position":1,"cik":"0001936203","reported_name":"Coulston James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2024-03-05T21:13:00.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2024."}],"balance_after":275000,"derivative":{"exercise_price":1.61,"expiration_date":"2034-03-01","underlying":"Class A Ordinary Shares","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000950170-24-025919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024025919/ownership.xml","form_type":"4"}},{"id":1597207,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2024-03-05T21:12:23.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":234742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 50% on the 1st anniversary of March 1, 2024 and the remaining 50% vests in substantially equal monthly installments for 12 months thereafter."}],"balance_after":234742,"derivative":{"exercise_price":1.61,"expiration_date":"2034-03-01","underlying":"Class A Ordinary Shares","underlying_shares":234742},"source":{"system":"sec-edgar","filing":"0000950170-24-025916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024025916/ownership.xml","form_type":"4"}},{"id":1597206,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":38215,"kind":"person","name":"Girolamo Todd C","position":1,"cik":"0001891257","reported_name":"Girolamo Todd C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2024-03-05T21:12:23.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2024."}],"balance_after":300000,"derivative":{"exercise_price":1.61,"expiration_date":"2034-03-01","underlying":"Class A Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-24-025916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024025916/ownership.xml","form_type":"4"}},{"id":1597666,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":63390,"kind":"person","name":"Weber Darin J.","position":1,"cik":"0001936228","reported_name":"Weber Darin J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Development"}}],"security":"Employee stock option (right to buy)","published_at":"2024-03-05T16:12:12.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":117264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 50% on the 1st anniversary of March 1, 2024 and the remaining 50% vests in substantially equal monthly installments for 12 months thereafter."}],"balance_after":117264,"derivative":{"exercise_price":1.61,"expiration_date":"2034-03-01","underlying":"Class A Ordinary Shares","underlying_shares":117264},"source":{"system":"sec-edgar","filing":"0000950170-24-025912","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936228/000095017024025912/ownership.xml","form_type":"4"}}],"next_cursor":"2024-03-05T16:12:12.000000Z,1597666"}